Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes
NCT: NCT07278531 · NOT_YET_RECRUITING
Brief Summary
The investigators will examine the feasibility, acceptability, and effect of an adaptive dietary intervention over 24 weeks (12-week intervention, 12-week follow-up) among Asian Americans with Type 2 diabetes. Participants (N=120; 60 Chinese Americans and 60 Vietnamese Americans) will be 2:1 randomized to one of two arms: adaptive dietary intervention or standard of care (SC). The intervention will begin with continued glucose monitoring (CGM) use only during weeks 0-4. At week 4, participants who achieve the glycemic control goal (at least an 8% increase in time in range \[TIR\] from baseline) will continue with the CGM alone during weeks 4-12 ("CGM Alone"); otherwise, culturally and linguistically adapted glucose excursion minimization (GEM) will be augmented with CGM ("CGM-GEM").
Frequently Asked Questions
What is Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes?
Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes is a clinical trial registered under NCT07278531. Current status: NOT_YET_RECRUITING.
What is the status of NCT07278531?
The current status of NCT07278531 (Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes) is: NOT_YET_RECRUITING.
When did Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes start?
Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes started on 2027-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.